Neumodx Molecular, Inc.

Neumodx Molecular, Inc. — FDA 510(k) Submissions

Neumodx Molecular, Inc. has submitted 2 FDA 510(k) premarket notifications since 2018, of which 2 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test, Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections . Use the specialty filter in the sidebar to narrow results.